Michael Bauguess
Physician Assistant · Oroville, CANPI 1912986647
Payments from drug & device makers
Across 439 payments — averaging $37.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$4K
- Viiv Healthcare Company$2K
- Janssen Scientific Affairs, LLC$1K
- Merck$1K
- AbbVie$1K
- Amgen$825
- plus $6K from 32 others
What the payments were for
- Consulting fees$1,1607%
- Travel & lodging$2762%
- Food & beverage$15,05391%
- Education$991%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 88 | $3,693 |
| Viiv Healthcare Company | 57 | $2,272 |
| Janssen Scientific Affairs, LLC | 3 | $1,340 |
| Merck | 45 | $1,233 |
| AbbVie | 39 | $1,092 |
| Amgen | 29 | $825 |
| Novo Nordisk | 19 | $670 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 16 | $527 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $507 |
| Pfizer | 21 | $410 |
| Bayer | 19 | $396 |
| AstraZeneca | 9 | $323 |
| Vanda Pharmaceuticals Inc. | 4 | $316 |
| Daiichi Sankyo Inc. | 12 | $311 |
| EMD Serono, Inc. | 11 | $280 |
| Otsuka America Pharmaceutical, Inc. | 3 | $232 |
| Sanofi | 2 | $218 |
| Medtronic | 3 | $199 |
| Lilly USA, LLC | 6 | $176 |
| Braeburn Inc. | 11 | $165 |
| Boehringer Ingelheim | 2 | $155 |
| GSK | 4 | $151 |
| Idorsia Pharmaceuticals US Inc | 4 | $141 |
| Stryker | 1 | $125 |
| Johnson & Johnson | 2 | $123 |
| Neurocrine Biosciences, Inc. | 1 | $119 |
| Janssen Products, LP | 1 | $99 |
| Abbott | 1 | $94 |
| Indivior Inc. | 3 | $74 |
| Viatris Specialty LLC | 3 | $66 |
| Exact Sciences | 3 | $61 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 5 | $42 |
| Sanofi Pasteur Inc. | 1 | $26 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| Theratechnologies Inc. | 1 | $22 |
| Eisai Inc. | 1 | $21 |
| Scilex Pharmaceuticals Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,588 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 210 | $826,265 |
| TivicayDolutegravir Sodium | 90 | $212,629 |
| SerostimSomatropin | 14 | $176,625 |
| OzempicSemaglutide | 135 | $135,148 |
| JardianceEmpagliflozin | 151 | $130,601 |
| DescovyEmtricitabine/Tenofov Alafenam | 47 | $108,528 |
| DovatoDolutegravir Sodium/Lamivudine | 24 | $67,660 |
| JanuviaSitagliptin Phosphate | 50 | $40,902 |
| PrezcobixDarunavir/Cobicistat | 14 | $40,382 |
| TradjentaLinagliptin | 62 | $38,200 |
| VraylarCariprazine Hcl | 23 | $31,648 |
| DelstrigoDoravirine/Lamivu/Tenofov Diso | 12 | $29,155 |
| ProliaDenosumab | 18 | $28,117 |
| PifeltroDoravirine | 16 | $28,097 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 36 | $23,950 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Descovy | $3,693 | $934,793257 claims |
| Viiv Healthcare CompanyTivicay, Dovato | $2,272 | $280,288114 claims |
| EMD Serono, Inc.Serostim | $280 | $176,62514 claims |
| Boehringer IngelheimJardiance, Tradjenta | $155 | $168,801213 claims |
| Novo NordiskOzempic | $670 | $135,148135 claims |
| MerckJanuvia, Delstrigo, Pifeltro, Belsomra, Steglatro | $1,233 | $111,270114 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Incruse Ellipta, Breo Ellipta, Shingrix | $151 | $57,719116 claims |
| AbbVieVraylar, Linzess | $1,092 | $47,78647 claims |
| Johnson & JohnsonPrezcobix, Invokana | $123 | $47,24326 claims |
| AmgenProlia | $825 | $28,11718 claims |
| BayerKerendia | $396 | $16,80022 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.
Other physician assistant in Oroville
- Steve KrikoriantzOroville$68K
- John QuigleyDowney$2.9M
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
- Heather AustinSalinas$219K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.